, Tracking Stock Market Picks
Enter Symbol:
Mast Therapeutics Inc. (MSTX) [hlAlert]

Above Average
down 79.51 %

Adventrx Pharmaceuticals, Inc. (ANX) rated Above Average with price target $6 by Caris & Company

Posted on: Monday,  Jun 7, 2010  10:25 AM ET by Caris & Company

Caris & Company rated Above Average Mast Therapeutics Inc. (AMEX: MSTX) on 06/07/2010, when the stock price was $2.05.
Since then, Mast Therapeutics Inc. has lost 79.51% as of 08/25/2015's recent price of $0.42.
If you would have followed this Caris & Company's recommendation on MSTX, you would have lost 79.51% of your investment in 1905 days.

ADVENTRX Pharmaceuticals, Inc. (ADVENTRX) is a development-stage biopharmaceutical company. The Company?s business is focused on in-licensing, developing and commercializing product candidates for the treatment of cancer. Its lead product candidates, ANX-530 and ANX-514, are emulsion formulations of marketed chemotherapy drugs. ADVENTRX is focused primarily on evaluating strategic options, including the sale or exclusive license of one or more of its product candidate programs, a strategic business merger and other similar transactions. In October 2008, ADVENTRX announced that it had discontinued active work on all product candidates other than ANX-530 and ANX-514. Its wholly owned subsidiaries include SD Pharmaceuticals, Inc. (SDP) and ADVENTRX (Europe) Ltd.

Caris & Company, an investment bank created by a diverse group of leading Wall Street professionals. We are founded on the basic principle that Wall Street requires a different type of organization: One that offers objective, conflict-free research, acute focus on customer service, broad institutional coverage, and an unwavering commitment to increasing the value of our clients' portfolios. Quite simply, our goal is to generate solid investment ideas for our clients. We offer a unique, differentiated, conflict-free research perspective on large, mid, and small capitalization companies in four growth oriented verticals: Health Care, Technology, Energy, and Consumer.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/7/2010 10:25 AM Buy
2.05 6.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy